Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	RRP1B MED1 DCC KMT2C CEBPZ TRIM28 MYOCD MAML2 THRAP3	1.03e-04	303	122	9	GO:0003713
GeneOntologyMolecularFunction	DNA secondary structure binding	BLM H1-0 KMT2A CLSPN	1.13e-04	41	122	4	GO:0000217
GeneOntologyMolecularFunction	double-stranded RNA binding	DDX60 STAU1 PRKRA DGCR8 TARBP2	1.16e-04	78	122	5	GO:0003725
GeneOntologyMolecularFunction	netrin receptor activity	DCC UNC5C	5.47e-04	6	122	2	GO:0005042
GeneOntologyMolecularFunction	chromo shadow domain binding	TRIM28 NIPBL	5.47e-04	6	122	2	GO:0070087
GeneOntologyMolecularFunction	transcription coregulator activity	RRP1B MED1 DCC KMT2C CEBPZ TRIM28 TCF25 MYOCD MAML2 NIPBL THRAP3	6.67e-04	562	122	11	GO:0003712
GeneOntologyMolecularFunction	deSUMOylase activity	USPL1 SENP5	7.62e-04	7	122	2	GO:0016929
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2C KMT2A	1.01e-03	8	122	2	GO:0140945
GeneOntologyMolecularFunction	histone binding	NBN MCM3AP CBX7 KMT2A MLLT1 MLLT6 FH	1.23e-03	265	122	7	GO:0042393
GeneOntologyMolecularFunction	pre-miRNA binding	PRKRA TARBP2	1.30e-03	9	122	2	GO:0070883
GeneOntologyBiologicalProcess	response to virus	HTRA1 RRP1B TAGAP SHFL DDX60 MAP3K14 PRKRA AGBL4 SETD2 PDE12 TRIM28 CXCR4 TARBP2	1.31e-06	425	121	13	GO:0009615
GeneOntologyBiologicalProcess	defense response to virus	HTRA1 TAGAP SHFL DDX60 MAP3K14 PRKRA AGBL4 SETD2 PDE12 TRIM28 TARBP2	5.58e-06	342	121	11	GO:0051607
GeneOntologyBiologicalProcess	miRNA processing	METTL3 PRKRA SRRT DGCR8 TARBP2	8.95e-06	48	121	5	GO:0035196
GeneOntologyBiologicalProcess	regulation of neuron migration	CXCR4 UNC5C CTNNA2 NIPBL PHACTR1	3.17e-05	62	121	5	GO:2001222
GeneOntologyBiologicalProcess	neuron migration	DCC NEO1 CXCR4 UNC5C CTNNA2 NIPBL PCNT PHACTR1	4.43e-05	218	121	8	GO:0001764
GeneOntologyBiologicalProcess	peptidyl-lysine modification	FSCB SETD2 TRIM28 KMT2A USPL1 TOPORS SENP5	4.83e-05	162	121	7	GO:0018205
GeneOntologyBiologicalProcess	regulatory ncRNA processing	METTL3 PRKRA SRRT DGCR8 TARBP2	7.45e-05	74	121	5	GO:0070918
GeneOntologyBiologicalProcess	viral process	MGAT4B RRP1B SHFL NBN CHMP4B BICD1 STAU1 PDE12 TRIM28 CXCR4 TARBP2	9.17e-05	464	121	11	GO:0016032
GeneOntologyBiologicalProcess	regulation of viral process	SHFL NBN STAU1 PDE12 TRIM28 CXCR4 TARBP2	1.15e-04	186	121	7	GO:0050792
GeneOntologyBiologicalProcess	pre-miRNA processing	PRKRA DGCR8 TARBP2	1.26e-04	17	121	3	GO:0031054
GeneOntologyBiologicalProcess	regulation of regulatory ncRNA processing	PRKRA DGCR8 TARBP2	1.51e-04	18	121	3	GO:0070920
GeneOntologyBiologicalProcess	RNA processing	METTL3 REXO4 RRP1B CDK12 U2SURP RBM23 RBM39 BICD1 PRKRA SRRT PDE12 UTP15 RRP12 CCNL1 PWP2 CTNNBL1 RP9 DGCR8 SAGE1 TARBP2 THRAP3	1.62e-04	1500	121	21	GO:0006396
GeneOntologyBiologicalProcess	regulation of viral genome replication	SHFL STAU1 PDE12 TRIM28 TARBP2	1.99e-04	91	121	5	GO:0045069
GeneOntologyBiologicalProcess	primary miRNA processing	METTL3 SRRT DGCR8	2.09e-04	20	121	3	GO:0031053
GeneOntologyBiologicalProcess	chromatin organization	METTL3 ARID4B NBN ZDBF2 KMT2C SETD2 TRIM28 MCM3AP H1-0 CBX7 KMT2A PWWP3A MLLT6 MYOCD NIPBL	2.42e-04	896	121	15	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	METTL3 ARID4B NBN ZDBF2 MED1 KMT2C SETD2 TRIM28 MCM3AP H1-0 CBX7 KMT2A PWWP3A MLLT6 MYOCD NIPBL	2.45e-04	999	121	16	GO:0071824
GeneOntologyBiologicalProcess	developmental growth	TNC SPART NBN MED1 DCC KMT2C BMPR2 ALMS1 TRIM28 CXCR4 ANKRD11 MYOCD NIPBL TARBP2 PCNT	2.89e-04	911	121	15	GO:0048589
GeneOntologyBiologicalProcess	regulation of viral life cycle	SHFL NBN STAU1 PDE12 TRIM28 TARBP2	3.19e-04	156	121	6	GO:1903900
GeneOntologyCellularComponent	nuclear body	METTL3 REXO4 AMER1 HIVEP1 CDK12 NBN PNISR RBM39 BLM SRRT CCNL1 NUFIP2 H1-0 RP9 DGCR8 SAGE1 MAML2 USPL1 TOPORS TARBP2 THRAP3	6.64e-08	903	123	21	GO:0016604
GeneOntologyCellularComponent	nuclear protein-containing complex	ELOA ARID4B CDK12 HMGXB4 NBN TEAD1 MED1 CHMP4B KMT2C CEBPZ TRIM28 CLMN MCM3AP CCNL1 PWP2 CTNNBL1 CBX7 KMT2A MLLT1 MYOCD DGCR8 SAGE1 NIPBL THRAP3	1.38e-06	1377	123	24	GO:0140513
GeneOntologyCellularComponent	nuclear speck	METTL3 REXO4 CDK12 PNISR RBM39 CCNL1 RP9 MAML2 TOPORS THRAP3	2.36e-04	431	123	10	GO:0016607
GeneOntologyCellularComponent	transcription elongation factor complex	ELOA CDK12 CCNL1 MLLT1	3.31e-04	56	123	4	GO:0008023
GeneOntologyCellularComponent	centriole	CEP162 AGBL4 C2CD3 ALMS1 TOPORS PCNT	5.46e-04	172	123	6	GO:0005814
Domain	DSRM	STAU1 PRKRA DGCR8 TARBP2	6.23e-06	19	122	4	SM00358
Domain	dsrm	STAU1 PRKRA DGCR8 TARBP2	7.74e-06	20	122	4	PF00035
Domain	DS_RBD	STAU1 PRKRA DGCR8 TARBP2	9.52e-06	21	122	4	PS50137
Domain	-	STAU1 PRKRA DGCR8 TARBP2	2.71e-05	27	122	4	3.30.160.20
Domain	dsRBD_dom	STAU1 PRKRA DGCR8 TARBP2	3.14e-05	28	122	4	IPR014720
Domain	Neogenin_C	DCC NEO1	4.23e-05	2	122	2	IPR010560
Domain	RBM39_linker	RBM23 RBM39	4.23e-05	2	122	2	IPR029123
Domain	RBM39linker	RBM23 RBM39	4.23e-05	2	122	2	PF15519
Domain	RBM39_SF	RBM23 RBM39	4.23e-05	2	122	2	IPR006509
Domain	Neogenin_C	DCC NEO1	4.23e-05	2	122	2	PF06583
Domain	Staufen_C	STAU1 PRKRA	1.26e-04	3	122	2	IPR032478
Domain	Staufen_C	STAU1 PRKRA	1.26e-04	3	122	2	PF16482
Domain	Post-SET_dom	KMT2C SETD2 KMT2A	1.43e-04	16	122	3	IPR003616
Domain	PostSET	KMT2C SETD2 KMT2A	1.43e-04	16	122	3	SM00508
Domain	POST_SET	KMT2C SETD2 KMT2A	1.43e-04	16	122	3	PS50868
Domain	EPHD	KMT2C KMT2A MLLT6	3.82e-04	22	122	3	PS51805
Domain	ZF_PHD_1	KMT2C PHF20L1 TRIM28 KMT2A MLLT6	4.17e-04	96	122	5	PS01359
Domain	FYrich_C	KMT2C KMT2A	4.18e-04	5	122	2	IPR003889
Domain	FYrich_N	KMT2C KMT2A	4.18e-04	5	122	2	IPR003888
Domain	FYRC	KMT2C KMT2A	4.18e-04	5	122	2	SM00542
Domain	FYRN	KMT2C KMT2A	4.18e-04	5	122	2	SM00541
Domain	FYRN	KMT2C KMT2A	4.18e-04	5	122	2	PF05964
Domain	FYRC	KMT2C KMT2A	4.18e-04	5	122	2	PF05965
Domain	FYRC	KMT2C KMT2A	4.18e-04	5	122	2	PS51543
Domain	FYRN	KMT2C KMT2A	4.18e-04	5	122	2	PS51542
Domain	RPEL	MYOCD PHACTR1	8.70e-04	7	122	2	PS51073
Domain	RPEL	MYOCD PHACTR1	8.70e-04	7	122	2	PF02755
Domain	RPEL	MYOCD PHACTR1	8.70e-04	7	122	2	SM00707
Domain	RPEL_repeat	MYOCD PHACTR1	8.70e-04	7	122	2	IPR004018
Domain	PHD	KMT2C TRIM28 KMT2A MLLT6	1.47e-03	75	122	4	PF00628
Domain	Znf_PHD-finger	KMT2C TRIM28 KMT2A MLLT6	1.78e-03	79	122	4	IPR019787
Domain	SET	KMT2C SETD2 KMT2A	2.42e-03	41	122	3	PF00856
Domain	PHD	KMT2C TRIM28 KMT2A MLLT6	2.76e-03	89	122	4	SM00249
Domain	Znf_FYVE_PHD	KMT2C PHF20L1 TRIM28 KMT2A MLLT6	2.80e-03	147	122	5	IPR011011
Domain	Znf_PHD	KMT2C TRIM28 KMT2A MLLT6	2.99e-03	91	122	4	IPR001965
Domain	SET	KMT2C SETD2 KMT2A	3.36e-03	46	122	3	SM00317
Domain	ZF_PHD_2	KMT2C TRIM28 KMT2A MLLT6	3.49e-03	95	122	4	PS50016
Domain	SET_dom	KMT2C SETD2 KMT2A	4.26e-03	50	122	3	IPR001214
Domain	SET	KMT2C SETD2 KMT2A	4.26e-03	50	122	3	PS50280
Domain	AT_hook	KMT2C KMT2A	4.78e-03	16	122	2	PF02178
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ELOA REXO4 HIVEP1 ARID4B RRP1B CDK12 C19orf53 U2SURP HMGXB4 NBN ZDBF2 MED1 RBM39 STAU1 BLM SRRT SETD2 CEBPZ TRIM28 NUFIP2 PWP2 ANKRD11 KMT2A MLLT1 MLLT6 RP9 DGCR8 NIPBL THRAP3 MRPL1	6.62e-20	954	126	30	36373674
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	METTL3 REXO4 RRP1B CDK12 C19orf53 HMGXB4 NBN MED1 CHMP4B PNISR RBM23 BLM SRRT CRACD KMT2C SETD2 UTP15 CEBPZ RRP12 CCNL1 NUFIP2 PWP2 CTNNBL1 ANKRD11 KMT2A MLLT1 RAI14 DGCR8 CTNNA2 CTNND2 NIPBL TARBP2	2.30e-16	1497	126	32	31527615
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ELOA REXO4 ARID4B RRP1B CDK12 CENPU MCM10 MED1 STAU1 CENPQ PRKRA BLM SRRT UTP15 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 TCF25 DGCR8 TARBP2	5.16e-14	759	126	22	35915203
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	RRP1B U2SURP STAU1 PRKRA SRRT ALMS1 CEBPZ RRP12 NUFIP2 H1-0 TCF25 DGCR8 TARBP2 THRAP3 SENP5	5.35e-12	364	126	15	24778252
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ARID4B RRP1B C19orf53 U2SURP HMGXB4 BAG2 NBN TEAD1 MED1 PNISR RBM39 BLM SRRT KMT2C SETD2 CEBPZ TRIM28 RRP12 H1-0 ANKRD11 KMT2A MLLT1 NIPBL THRAP3	4.22e-11	1294	126	24	30804502
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	ELOA REXO4 RRP1B U2SURP BAG2 MCM10 RBM39 STAU1 BLM SRRT UTP15 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 CTNNBL1 PWWP3A DGCR8 CLSPN THRAP3	7.04e-11	989	126	21	36424410
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ERICH1 ELOA REXO4 HIVEP1 ARID4B RRP1B HMGXB4 TEAD1 MCM10 MED1 BLM FSIP2 PHF20L1 CCNL1 KMT2A MLLT6 NIPBL	8.45e-11	608	126	17	36089195
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	REXO4 RRP1B CDK12 U2SURP RALGPS2 RBM39 STAU1 PRKRA SRRT CRACD CEBPZ TRIM28 RRP12 NUFIP2 H1-0 PWP2 CTNNBL1 THRAP3	1.76e-10	731	126	18	29298432
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ELOA CDK12 U2SURP SPART NBN MED1 CHMP4B RBM39 STAU1 CRACD SETD2 ALMS1 TRIM28 CLMN RRP12 NUFIP2 KMT2A RAI14 NIPBL PCNT	1.81e-10	934	126	20	33916271
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	REXO4 RRP1B U2SURP RBM39 STAU1 PRKRA BLM UTP15 CEBPZ RRP12 MCM3AP NUFIP2 PWP2 KMT2A FH NIPBL PCNT	2.53e-10	653	126	17	22586326
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 ELOA HIVEP1 ARID4B CDK12 NBN MED1 PNISR BLM SRRT SETD2 TRIM28 RRP12 CCNL1 KMT2A TOPORS NIPBL THRAP3	4.38e-10	774	126	18	15302935
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	ELOA REXO4 RRP1B U2SURP BAG2 RBM39 STAU1 SRRT CEBPZ TRIM28 RRP12 NUFIP2 H1-0 PWP2 KMT2A THRAP3	7.06e-10	605	126	16	28977666
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	REXO4 RRP1B U2SURP PNISR RBM39 STAU1 PRKRA SRRT UTP15 CEBPZ TRIM28 RRP12 NUFIP2 H1-0 PWP2 RP9 THRAP3 MRPL1	8.48e-10	807	126	18	22681889
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	METTL3 ARID4B CEP162 SPART NBN MCM10 MED1 CHMP4B C2CD3 ALMS1 NUFIP2 KMT2A RAI14 THRAP3 PCNT RPAP2	1.76e-09	645	126	16	25281560
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ELOA REXO4 GALC RRP1B CDK12 U2SURP HMGXB4 MED1 PNISR RBM39 STAU1 PRKRA BLM SRRT SETD2 TRIM28 RRP12 CTNNBL1 NIPBL THRAP3	2.28e-09	1082	126	20	38697112
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	ARID4B RRP1B CDK12 C19orf53 BAG2 CENPU RBM39 STAU1 SRRT CEBPZ TRIM28 NUFIP2 H1-0 PWP2 CTNNBL1 TCF25 CTNNA2 CLSPN MRPL1	2.38e-09	971	126	19	33306668
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	RRP1B MED1 RBM39 STAU1 BLM SRRT SETD2 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 RPAP2	8.35e-09	440	126	13	34244565
Pubmed	Human transcription factor protein interaction networks.	REXO4 HIVEP1 ARID4B RRP1B HMGXB4 BAG2 NBN TEAD1 CHMP4B STAU1 BLM SRRT KMT2C ALMS1 RRP12 KMT2A MLLT1 MLLT6 RAI14 NIPBL MRPL1 SENP5	9.28e-09	1429	126	22	35140242
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ERICH1 ELOA CDK12 BAG2 NBN ZDBF2 MCM10 STAU1 SETD2 NEO1 ALMS1 CEBPZ CLMN NUFIP2 CLSPN RPAP2	1.07e-08	733	126	16	34672954
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CDK12 NBN TEAD1 MED1 KMT2C SETD2 ALMS1 CEBPZ TRIM28 NUFIP2 KMT2A RAI14 THRAP3 RPAP2	1.38e-08	549	126	14	38280479
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	AMER1 HIVEP1 CEP162 PARP8 MAP3K14 RALGPS2 FSIP2 SRRT BMPR2 C2CD3 ALMS1 CLMN ANKRD11 FMN2 KMT2A RAI14 SH3RF3	1.57e-08	861	126	17	36931259
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	AMER1 RRP1B U2SURP BAG2 MED1 RBM39 STAU1 PRKRA SRRT CEBPZ TRIM28 NUFIP2 H1-0 MLLT1 MLLT6 RAI14 FH TOPORS THRAP3 RPAP2	2.44e-08	1247	126	20	27684187
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	ELOA REXO4 RRP1B U2SURP BAG2 CENPU STAU1 BLM UTP15 CEBPZ TRIM28 RRP12 DGCR8	2.50e-08	483	126	13	36912080
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	REXO4 RRP1B CDK12 C19orf53 U2SURP BAG2 RBM39 PRKRA TRIM28 RRP12 NUFIP2 H1-0 TCF25 THRAP3 MRPL1	2.68e-08	678	126	15	30209976
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	HTRA1 TNC PPFIA4 RBM39 STAU1 PRKRA AGBL4 SRRT CRACD TRIM28 CLMN NUFIP2 H1-0 MAST1 KMT2A RAI14 CTNNA2 CPNE4 CTNND2 FH THRAP3	4.76e-08	1431	126	21	37142655
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	RRP1B U2SURP BAG2 RBM39 STAU1 PRKRA TRIM28 RRP12 NUFIP2 H1-0 PWP2 DGCR8 THRAP3 RPAP2	5.66e-08	615	126	14	31048545
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	RRP1B CENPU BLM CEBPZ RRP12 KMT2A NIPBL THRAP3 PCNT	8.04e-08	210	126	9	16565220
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	REXO4 U2SURP BAG2 MCM10 RBM39 STAU1 PRKRA BLM SRRT PDE12 UTP15 CEBPZ TRIM28 RRP12 MCM3AP H1-0 CTNNBL1 RAI14 NIPBL THRAP3	9.20e-08	1353	126	20	29467282
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	CENPU NBN MCM10 MED1 BLM SRRT SETD2 TRIM28 PWWP3A DGCR8 SAGE1 TOPORS	1.05e-07	453	126	12	29656893
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ELOA REXO4 RRP1B SHFL CDK12 MED1 CHMP4B RBM23 STAU1 PRKRA SRRT CEBPZ MCM3AP NUFIP2 CTNNBL1 KMT2A RAI14 CTNNA2 TARBP2 THRAP3	1.14e-07	1371	126	20	36244648
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	RRP1B U2SURP RBM39 STAU1 PRKRA TRIM28 RRP12 MCM3AP NUFIP2 H1-0 RP9 TARBP2 THRAP3 SENP5	1.22e-07	655	126	14	35819319
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ELOA METTL3 REXO4 RRP1B DDX60 RBM39 STAU1 PRKRA SRRT UTP15 CEBPZ TRIM28 RRP12 NUFIP2 H1-0 PWP2 RAI14 TOPORS THRAP3	1.42e-07	1257	126	19	36526897
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	U2SURP BAG2 ZDBF2 RBM39 STAU1 PRKRA NEO1 TRIM28 ELFN1 NUFIP2 H1-0 TCF25 CTNNA2 CPNE4 CTNND2 THRAP3 JPH3 PHACTR1	1.64e-07	1139	126	18	36417873
Pubmed	Motor axon guidance of the mammalian trochlear and phrenic nerves: dependence on the netrin receptor Unc5c and modifier loci.	DCC NEO1 UNC5C	1.85e-07	4	126	3	16723533
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	REXO4 HIVEP1 RRP1B U2SURP CHMP4B RBM39 STAU1 SRRT PDE12 UTP15 CEBPZ TRIM28 CXCR4 RRP12 H1-0 PWP2 CTNNBL1 FH NIPBL THRAP3	2.11e-07	1425	126	20	30948266
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	METTL3 HIVEP1 SPART NBN ZDBF2 BLM SETD2 ALMS1 MCM3AP CLSPN TOPORS PCNT RPAP2	2.42e-07	588	126	13	38580884
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ELOA AMER1 PPFIA4 PARP8 U2SURP DNAH2 DCC PNISR C2CD3 PHF20L1 CEBPZ UNC5C H1-0 PWP2 KMT2A MLLT1 USPL1 NIPBL THRAP3 PCNT	2.54e-07	1442	126	20	35575683
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	C19orf53 U2SURP BAG2 RBM39 BLM KMT2C RRP12 ANKRD11 KMT2A RAI14 RP1 SH3RF3	2.84e-07	497	126	12	36774506
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	METTL3 RRP1B CDK12 NBN MED1 BLM SRRT TRIM28 RRP12 NUFIP2 NIPBL THRAP3	3.22e-07	503	126	12	16964243
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	ELOA RRP1B CDK12 C19orf53 U2SURP RBM39 STAU1 PRKRA SRRT RRP12 RAI14 DGCR8 THRAP3 MRPL1	3.40e-07	713	126	14	29802200
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	CDK12 PNISR KMT2C TRIM28 H1-0 CTNNBL1 KMT2A THRAP3 PCNT	3.64e-07	251	126	9	31076518
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	REXO4 RRP1B STAU1 PRKRA UTP15 CEBPZ RRP12 MCM3AP H1-0 PWP2	3.98e-07	332	126	10	25693804
Pubmed	Netrin 1 acts as an attractive or as a repulsive cue for distinct migrating neurons during the development of the cerebellar system.	DCC NEO1 UNC5C	4.62e-07	5	126	3	10704383
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	ELOA RRP1B ZDBF2 MCM10 RBM39 BLM RRP12 PWP2 KMT2A CLSPN	4.81e-07	339	126	10	30415952
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	HTRA1 ARID4B HMGXB4 BAG2 NBN SETD2 ALMS1 TRIM28 MCM3AP CTNNBL1 TCF25 FMN2 MLLT1 CLSPN TOPORS TARBP2 RPAP2	6.20e-07	1116	126	17	31753913
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	REXO4 RRP1B NBN CHMP4B STAU1 UTP15 CEBPZ RRP12 NUFIP2 PWP2	6.26e-07	349	126	10	25665578
Pubmed	Netrin-1 promotes thalamic axon growth and is required for proper development of the thalamocortical projection.	DCC NEO1 UNC5C	9.21e-07	6	126	3	10908620
Pubmed	Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.	PRKRA DGCR8 TARBP2	9.21e-07	6	126	3	22025453
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	U2SURP HMGXB4 MED1 CHMP4B PNISR RBM39 H1-0 MLLT1 RPAP2	9.88e-07	283	126	9	28533407
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	METTL3 ARID4B PPFIA4 U2SURP BAG2 TRIM28 RP1 THRAP3 PCNT	1.02e-06	284	126	9	29459677
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	ELOA CDK12 U2SURP CENPU DCC RBM39 STAU1 PRKRA ALMS1 RAI14 THRAP3 PCNT RPAP2	1.04e-06	670	126	13	22990118
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ELOA ARID4B C19orf53 ZDBF2 TEAD1 MED1 RBM39 CRACD KMT2C SETD2 TRIM28 MCM3AP ANKRD11 KMT2A MAML2 CLSPN NIPBL PCNT	1.48e-06	1327	126	18	32694731
Pubmed	Cloning of three mouse Unc5 genes and their expression patterns at mid-gestation.	DCC NEO1 UNC5C	1.61e-06	7	126	3	12351186
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	U2SURP BAG2 RBM39 STAU1 SRRT TRIM28 NUFIP2 PWP2	1.65e-06	223	126	8	20020773
Pubmed	Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.	C19orf53 HMGXB4 PHF20L1 RRP12 TOPORS	1.90e-06	56	126	5	26919559
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RRP1B U2SURP BAG2 CHMP4B RBM39 UTP15 CEBPZ TRIM28 RRP12 NUFIP2 H1-0 TCF25 RAI14 RP9 THRAP3	1.91e-06	949	126	15	36574265
Pubmed	Protein phosphatase 1γ isoforms linked interactions in the brain.	RRP1B ZDBF2 STAU1 BMPR2 CLMN	2.07e-06	57	126	5	23080069
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	TNC RBM39 CLMN CTNNA2 CTNND2 THRAP3 JPH3 PHACTR1	2.15e-06	231	126	8	16452087
Pubmed	Floor plate and netrin-1 are involved in the migration and survival of inferior olivary neurons.	DCC NEO1 UNC5C	2.57e-06	8	126	3	10341242
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	RRP1B NBN MED1 CHMP4B SRRT TRIM28 H1-0 KMT2A TOPORS THRAP3	2.71e-06	411	126	10	35182466
Pubmed	Nucleolar proteome dynamics.	ELOA RRP1B C19orf53 RBM39 BLM CEBPZ TRIM28 RRP12 CTNNBL1 NIPBL	3.22e-06	419	126	10	15635413
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	METTL3 RRP1B HMGXB4 MED1 RBM39 TRIM28 RRP12 H1-0 PWP2 KMT2A NIPBL	4.11e-06	533	126	11	30554943
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	BAG2 NBN MED1 SRRT MCM3AP NUFIP2 TCF25 KMT2A THRAP3	4.54e-06	341	126	9	32971831
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	RRP1B DDX60 BAG2 MAP3K14 CHMP4B RBM39 STAU1 PRKRA CRACD CEBPZ TRIM28 CXCR4 RRP12 H1-0 KMT2A CTNNA2 THRAP3 MRPL1	4.63e-06	1440	126	18	30833792
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	CRACD TRIM28 RAI14 CTNNA2 CTNND2	4.65e-06	67	126	5	29254152
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	HMGXB4 BAG2 BLM KMT2C KMT2A NIPBL	4.98e-06	119	126	6	23508102
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ERICH1 REXO4 AMER1 CEP162 MCM10 BLM NEO1 UNC5C PWWP3A RAI14 DGCR8 CLSPN THRAP3	5.26e-06	777	126	13	35844135
Pubmed	Dynein and kinesin regulate stress-granule and P-body dynamics.	DNAH2 BICD1 STAU1	5.47e-06	10	126	3	19825938
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RRP1B U2SURP BAG2 RBM39 UTP15 CEBPZ TRIM28 RRP12 H1-0 PWP2 CTNNBL1 KMT2A RP9 FH NIPBL THRAP3 MRPL1	5.80e-06	1318	126	17	30463901
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	TAGAP DCC AGBL4 KMT2C CXCR4 MAML2 CTNNA2 CTNND2	5.91e-06	265	126	8	19240061
Pubmed	Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.	NBN RBM39 SRRT TRIM28 CCNL1 CTNNBL1 THRAP3	5.92e-06	188	126	7	29721183
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	DDX60 ZDBF2 RBM39 PWP2 ANKRD11 MLLT1 NIPBL THRAP3	7.15e-06	272	126	8	31010829
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	AMER1 HIVEP1 RRP1B CDK12 HMGXB4 PNISR RBM39 CTNND2 THRAP3	7.18e-06	361	126	9	26167880
Pubmed	Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis.	DCC NEO1 UNC5C	7.50e-06	11	126	3	15186747
Pubmed	Analysis of Netrin 1 receptors during inner ear development.	DCC NEO1 UNC5C	7.50e-06	11	126	3	17616930
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	BAG2 STAU1 PRKRA C2CD3 NUFIP2 PWP2 DGCR8 TARBP2 THRAP3 MRPL1	7.58e-06	462	126	10	31138677
Pubmed	The protein interaction landscape of the human CMGC kinase group.	RRP1B CDK12 MED1 RBM23 RBM39 STAU1 PRKRA SETD2 ALMS1 MLLT1 DGCR8 THRAP3	9.03e-06	695	126	12	23602568
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ELOA REXO4 RRP1B CDK12 MED1 BLM TRIM28 THRAP3	9.54e-06	283	126	8	30585729
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	ELOA REXO4 CDK12 DDX60 SPART BICD1 BLM PCNT	1.00e-05	285	126	8	32838362
Pubmed	Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.	ELOA REXO4 RRP1B CENPU RBM23 RBM39 STAU1 TRIM28 NUFIP2 FH TARBP2 THRAP3	1.03e-05	704	126	12	32994395
Pubmed	Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways.	U2SURP SRRT TRIM28	1.29e-05	13	126	3	20858735
Pubmed	The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.	KMT2A MLLT1	1.30e-05	2	126	2	36435883
Pubmed	SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia.	SETD2 KMT2A	1.30e-05	2	126	2	29249820
Pubmed	unc5c haploinsufficient phenotype: striking similarities with the dcc haploinsufficiency model.	DCC UNC5C	1.30e-05	2	126	2	23738838
Pubmed	Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.	TNC BMPR2	1.30e-05	2	126	2	16782755
Pubmed	Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation.	RBM39 KMT2A	1.30e-05	2	126	2	34077726
Pubmed	Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions.	GALC TNC	1.30e-05	2	126	2	25192051
Pubmed	MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.	SETD2 KMT2A	1.30e-05	2	126	2	29777171
Pubmed	Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.	KMT2A MLLT1	1.30e-05	2	126	2	8378076
Pubmed	Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.	DCC UNC5C	1.30e-05	2	126	2	18054557
Pubmed	Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene.	CXCR4 MAML2	1.30e-05	2	126	2	24855209
Pubmed	First case of B ALL with KMT2A-MAML2 rearrangement: a case report.	KMT2A MAML2	1.30e-05	2	126	2	28535805
Pubmed	METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.	METTL3 DGCR8	1.30e-05	2	126	2	36068012
Pubmed	KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.	KMT2A MAML2	1.30e-05	2	126	2	34550633
Pubmed	KAP1 represses differentiation-inducible genes in embryonic stem cells through cooperative binding with PRC1 and derepresses pluripotency-associated genes.	TRIM28 CBX7	1.30e-05	2	126	2	24687849
Pubmed	Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.	DCC UNC5C	1.30e-05	2	126	2	19242752
Pubmed	Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.	KMT2A MLLT1	1.30e-05	2	126	2	17252016
Pubmed	TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA.	MED1 THRAP3	1.30e-05	2	126	2	12130544
Pubmed	The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function.	TEAD1 MYOCD	1.30e-05	2	126	2	24344135
Pubmed	Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.	KMT2A MLLT1	1.30e-05	2	126	2	21953510
Interaction	SMC5 interactions	ELOA REXO4 HIVEP1 ARID4B RRP1B CDK12 C19orf53 U2SURP HMGXB4 NBN ZDBF2 MED1 RBM39 STAU1 BLM SRRT SETD2 CEBPZ TRIM28 NUFIP2 PWP2 ANKRD11 KMT2A MLLT1 MLLT6 RP9 DGCR8 NIPBL THRAP3 MRPL1	1.81e-13	1000	122	30	int:SMC5
Interaction	SOX2 interactions	ELOA REXO4 GALC HIVEP1 ARID4B RRP1B SHFL CDK12 BAG2 ZDBF2 TEAD1 MED1 CHMP4B STAU1 PRKRA KMT2C SETD2 C2CD3 PHF20L1 UTP15 TRIM28 RRP12 NUFIP2 KMT2A MLLT1 RAI14 DGCR8 NIPBL TARBP2 THRAP3 MRPL1 PCNT	5.10e-11	1422	122	32	int:SOX2
Interaction	H3-3A interactions	ERICH1 ELOA REXO4 HIVEP1 ARID4B RRP1B HMGXB4 TEAD1 MCM10 MED1 BLM KMT2C PHF20L1 TRIM28 CCNL1 H1-0 CBX7 KMT2A MLLT6 FH NIPBL THRAP3	7.28e-10	749	122	22	int:H3-3A
Interaction	HECTD1 interactions	ELOA REXO4 ARID4B RRP1B CDK12 U2SURP CENPU MCM10 MED1 RBM39 STAU1 CENPQ PRKRA BLM SRRT UTP15 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 ANKRD11 TCF25 DGCR8 TARBP2	8.66e-10	984	122	25	int:HECTD1
Interaction	NUP43 interactions	REXO4 HIVEP1 ARID4B RRP1B CDK12 DDX60 ZDBF2 RBM39 BLM FSIP2 SRRT SETD2 PHF20L1 CEBPZ MCM3AP H1-0 ANKRD11 KMT2A MLLT6 NIPBL	1.10e-09	625	122	20	int:NUP43
Interaction	CENPA interactions	REXO4 HIVEP1 RRP1B HMGXB4 CENPU MCM10 CENPQ BLM SRRT CEBPZ RRP12 ANKRD11 KMT2A MLLT1 MLLT6 NIPBL	1.11e-09	377	122	16	int:CENPA
Interaction	SRSF6 interactions	REXO4 RRP1B CDK12 U2SURP CENPU RBM23 RBM39 STAU1 PRKRA SRRT SETD2 CEBPZ RRP12 KMT2A DGCR8 TOPORS TARBP2 THRAP3	1.42e-09	503	122	18	int:SRSF6
Interaction	DHX40 interactions	ELOA RRP1B ZDBF2 PNISR RBM39 BLM SETD2 CEBPZ RRP12 ANKRD11 DGCR8 CLSPN THRAP3	3.81e-09	249	122	13	int:DHX40
Interaction	TERF2IP interactions	ERICH1 ELOA METTL3 HIVEP1 CDK12 U2SURP HMGXB4 NBN MCM10 MED1 BLM SETD2 TRIM28 ANKRD11 KMT2A DGCR8 CLSPN NIPBL	6.11e-09	552	122	18	int:TERF2IP
Interaction	NIFK interactions	ELOA REXO4 RRP1B MCM10 RBM39 STAU1 PRKRA BLM CEBPZ TRIM28 RRP12 ANKRD11 MAST1 RP9 DGCR8 TOPORS	7.53e-09	431	122	16	int:NIFK
Interaction	RPL13 interactions	METTL3 REXO4 RRP1B CDK12 U2SURP MAP3K14 CENPU DCC CHMP4B RBM39 STAU1 CENPQ PRKRA PDE12 CEBPZ RRP12 KMT2A TOPORS TARBP2 MRPL1	7.59e-09	700	122	20	int:RPL13
Interaction	SRPK2 interactions	REXO4 AMER1 HIVEP1 RRP1B CDK12 U2SURP HMGXB4 PNISR RBM23 RBM39 STAU1 PRKRA SRRT SETD2 ALMS1 CEBPZ RRP12 CTNNBL1 DGCR8 THRAP3	1.13e-08	717	122	20	int:SRPK2
Interaction	PRKRA interactions	REXO4 RRP1B CDK12 MAP3K14 CENPU RBM39 STAU1 PRKRA CEBPZ TRIM28 H1-0 MAST1 KMT2A DGCR8 TARBP2	2.01e-08	400	122	15	int:PRKRA
Interaction	CSNK2B interactions	ERICH1 HTRA1 RRP1B U2SURP CHMP4B RBM39 STAU1 BLM SETD2 CCNL1 ANKRD11 CBX7 MAST1 KMT2A RP9 CLSPN TOPORS THRAP3	4.11e-08	625	122	18	int:CSNK2B
Interaction	FGFBP1 interactions	REXO4 RRP1B CDK12 CENPU STAU1 PRKRA CEBPZ RRP12 H1-0 PWP2 KMT2A DGCR8	5.37e-08	257	122	12	int:FGFBP1
Interaction	NOP56 interactions	ELOA REXO4 RRP1B MCM10 CHMP4B RBM39 STAU1 BLM BMPR2 CEBPZ TRIM28 RRP12 ANKRD11 MLLT1 MLLT6 RP9 DGCR8	6.14e-08	570	122	17	int:NOP56
Interaction	UTP4 interactions	ZDBF2 CHMP4B STAU1 BLM UTP15 CEBPZ TRIM28 ANKRD11 CLSPN PCNT	8.55e-08	170	122	10	int:UTP4
Interaction	H3C1 interactions	ELOA REXO4 ARID4B RRP1B U2SURP HMGXB4 DNAH2 NBN STAU1 BLM KMT2C SETD2 TRIM28 RRP12 H1-0 CTNNBL1 CBX7 KMT2A MLLT1 NIPBL THRAP3	1.02e-07	901	122	21	int:H3C1
Interaction	RPL13A interactions	REXO4 RRP1B CDK12 MAP3K14 DCC RBM39 STAU1 PRKRA PDE12 CEBPZ PWP2 TCF25 KMT2A DGCR8 TARBP2 MRPL1 PCNT	1.03e-07	591	122	17	int:RPL13A
Interaction	RPL15 interactions	REXO4 CDK12 U2SURP MAP3K14 CENPU MCM10 CHMP4B RBM39 STAU1 PRKRA CEBPZ RRP12 PWP2 TCF25 TOPORS TARBP2	1.32e-07	530	122	16	int:RPL15
Interaction	NLE1 interactions	REXO4 RRP1B CDK12 CHMP4B STAU1 PRKRA BLM SETD2 CEBPZ TRIM28 CLSPN	1.42e-07	228	122	11	int:NLE1
Interaction	RPL4 interactions	REXO4 RRP1B CDK12 U2SURP MAP3K14 CENPU CHMP4B RBM39 STAU1 CENPQ PRKRA PDE12 CEBPZ RRP12 NUFIP2 PWP2 ANKRD11 DGCR8 TARBP2	1.66e-07	764	122	19	int:RPL4
Interaction	MECP2 interactions	ELOA REXO4 GALC RRP1B CDK12 U2SURP HMGXB4 MED1 CHMP4B PNISR RBM39 STAU1 PRKRA BLM SRRT SETD2 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 CTNNBL1 DGCR8 NIPBL THRAP3	1.76e-07	1287	122	25	int:MECP2
Interaction	NPM1 interactions	FILIP1 METTL3 REXO4 HIVEP1 RRP1B BAG2 CHMP4B RBM39 BICD1 STAU1 PRKRA SRRT SETD2 UTP15 CEBPZ TRIM28 RRP12 UNC5C NUFIP2 CTNNBL1 KMT2A RP1 MRPL1 SENP5	1.94e-07	1201	122	24	int:NPM1
Interaction	MAGEB2 interactions	REXO4 RRP1B CDK12 CENPU RBM23 STAU1 PRKRA BLM CEBPZ TRIM28 PWP2 DGCR8 TARBP2	2.03e-07	349	122	13	int:MAGEB2
Interaction	DDX23 interactions	ELOA REXO4 RRP1B CDK12 U2SURP PNISR RBM39 STAU1 SETD2 CEBPZ RRP12 ANKRD11 MLLT1 RP9 THRAP3	2.16e-07	480	122	15	int:DDX23
Interaction	SRPK3 interactions	REXO4 RRP1B U2SURP RBM23 RBM39 STAU1 PRKRA SRRT CEBPZ THRAP3	2.42e-07	190	122	10	int:SRPK3
Interaction	POLR1G interactions	ELOA REXO4 ARID4B RRP1B NBN BLM CEBPZ RRP12 PWP2 ANKRD11 KMT2A MLLT1 CLSPN NIPBL RPAP2	2.74e-07	489	122	15	int:POLR1G
Interaction	SRSF4 interactions	REXO4 CDK12 U2SURP RBM23 RBM39 STAU1 CENPQ TRIM28 KMT2A TOPORS THRAP3 MRPL1	2.87e-07	300	122	12	int:SRSF4
Interaction	SNRNP40 interactions	REXO4 HIVEP1 RRP1B CDK12 ZDBF2 PNISR RBM39 BLM SRRT SETD2 PHF20L1 CEBPZ CTNNBL1 KMT2A MLLT6 RP9 SAGE1	2.98e-07	637	122	17	int:SNRNP40
Interaction	ZC3H18 interactions	REXO4 RRP1B CDK12 U2SURP RALGPS2 CHMP4B RBM39 STAU1 PRKRA SRRT CRACD CEBPZ TRIM28 RRP12 NUFIP2 H1-0 PWP2 CTNNBL1 TOPORS THRAP3	3.02e-07	877	122	20	int:ZC3H18
Interaction	ZNF330 interactions	ELOA REXO4 ARID4B RRP1B HMGXB4 STAU1 BLM CEBPZ RRP12 ANKRD11 KMT2A MLLT1 MLLT6 NIPBL	5.35e-07	446	122	14	int:ZNF330
Interaction	SIRT7 interactions	REXO4 RRP1B U2SURP RBM39 STAU1 PRKRA BLM UTP15 CEBPZ RRP12 MCM3AP NUFIP2 PWP2 CTNNBL1 KMT2A FH NIPBL PCNT	5.42e-07	744	122	18	int:SIRT7
Interaction	MYCN interactions	REXO4 RRP1B CDK12 C19orf53 U2SURP HMGXB4 BAG2 CENPU RBM39 STAU1 PRKRA SRRT SETD2 CEBPZ TRIM28 RRP12 NUFIP2 H1-0 KMT2A RP9 DGCR8 TARBP2 THRAP3 MRPL1 RPAP2	5.90e-07	1373	122	25	int:MYCN
Interaction	CHD3 interactions	ELOA REXO4 ARID4B RRP1B U2SURP HMGXB4 TEAD1 RBM39 STAU1 SRRT PHF20L1 CEBPZ TRIM28 RRP12 PWP2 KMT2A THRAP3 PCNT	6.97e-07	757	122	18	int:CHD3
Interaction	RPS24 interactions	ELOA REXO4 RRP1B MAP3K14 DCC CHMP4B PNISR RBM39 PRKRA BLM CEBPZ RRP12 PWP2 CTNNBL1 ANKRD11	7.40e-07	529	122	15	int:RPS24
Interaction	UBR5 interactions	METTL3 RRP1B CDK12 DDX60 U2SURP HMGXB4 NBN CHMP4B RBM39 BICD1 UTP15 TRIM28 CCNL1 MAST1 MYOCD	8.14e-07	533	122	15	int:UBR5
Interaction	TOP1 interactions	METTL3 ARID4B RRP1B CHMP4B RBM39 STAU1 SRRT SETD2 TRIM28 NUFIP2 CTNNBL1 KMT2A FH TOPORS NIPBL TARBP2 THRAP3	1.02e-06	696	122	17	int:TOP1
Interaction	SRSF5 interactions	REXO4 CDK12 U2SURP MAP3K14 CENPU CHMP4B STAU1 CENPQ PRKRA CEBPZ TRIM28 H1-0 KMT2A MRPL1	1.10e-06	474	122	14	int:SRSF5
Interaction	MDC1 interactions	U2SURP BAG2 CENPU NBN RBM39 STAU1 PRKRA SETD2 TRIM28 PWWP3A RAI14 DGCR8 THRAP3	1.39e-06	414	122	13	int:MDC1
Interaction	IFI16 interactions	ELOA REXO4 RRP1B U2SURP RBM39 STAU1 PRKRA UTP15 CEBPZ TRIM28 RRP12 MCM3AP NUFIP2 H1-0 PWP2 RAI14 RP9	1.44e-06	714	122	17	int:IFI16
Interaction	ZNF467 interactions	REXO4 CENPU STAU1 PRKRA BLM CEBPZ RRP12 PWP2 MYOCD	1.45e-06	179	122	9	int:ZNF467
Interaction	POLR1E interactions	ELOA HIVEP1 RRP1B ZDBF2 BLM CEBPZ RRP12 PWP2 KMT2A MLLT1 MLLT6 RPAP2	1.46e-06	350	122	12	int:POLR1E
Interaction	NAA40 interactions	ELOA CDK12 U2SURP SPART NBN MED1 CHMP4B RBM39 STAU1 CRACD SETD2 ALMS1 TRIM28 CLMN RRP12 NUFIP2 KMT2A RAI14 NIPBL PCNT	1.65e-06	978	122	20	int:NAA40
Interaction	LIN28A interactions	REXO4 RRP1B CDK12 U2SURP RBM39 STAU1 PRKRA SRRT CEBPZ TRIM28 RRP12 H1-0 MRPL1	1.68e-06	421	122	13	int:LIN28A
Interaction	ABT1 interactions	REXO4 AMER1 RRP1B CDK12 STAU1 PRKRA BLM CEBPZ RRP12 KMT2A DGCR8 TOPORS TARBP2	1.77e-06	423	122	13	int:ABT1
Interaction	RPL28 interactions	REXO4 RRP1B CDK12 MAP3K14 CENPU ZDBF2 DCC RBM39 STAU1 CENPQ PRKRA PDE12 CEBPZ MCM3AP	1.79e-06	494	122	14	int:RPL28
Interaction	CBX3 interactions	ERICH1 ELOA REXO4 AMER1 CDK12 HMGXB4 MED1 RBM39 BLM SRRT SETD2 TRIM28 KMT2A RP9 CLSPN NIPBL	1.82e-06	646	122	16	int:CBX3
Interaction	RPL36 interactions	REXO4 RRP1B CDK12 MAP3K14 CENPU CHMP4B RBM39 STAU1 CENPQ PRKRA CEBPZ PWP2 KMT2A TOPORS	2.26e-06	504	122	14	int:RPL36
Interaction	RC3H2 interactions	REXO4 RRP1B CDK12 C19orf53 U2SURP BAG2 RBM39 STAU1 PRKRA TRIM28 RRP12 NUFIP2 H1-0 TCF25 THRAP3 MRPL1	2.74e-06	667	122	16	int:RC3H2
Interaction	RPL31 interactions	ELOA REXO4 RRP1B C19orf53 U2SURP MCM10 CHMP4B RBM39 STAU1 PRKRA BLM CEBPZ RRP12 ANKAR ANKRD11 RP9	3.51e-06	680	122	16	int:RPL31
Interaction	GNL2 interactions	ELOA REXO4 CENPU MCM10 STAU1 PRKRA BLM CEBPZ RRP12 PWP2 RP9 DGCR8	4.02e-06	386	122	12	int:GNL2
Interaction	RRP8 interactions	REXO4 RRP1B MAP3K14 CENPU CHMP4B STAU1 PRKRA CEBPZ RRP12 DGCR8	4.03e-06	259	122	10	int:RRP8
Interaction	CIT interactions	RRP1B DDX60 BAG2 TEAD1 MED1 CHMP4B RBM23 RBM39 BICD1 ALMS1 UTP15 CEBPZ TRIM28 ELFN1 RRP12 NUFIP2 PWP2 CTNNBL1 TCF25 KMT2A RAI14 RP9 NIPBL THRAP3	5.44e-06	1450	122	24	int:CIT
Interaction	SIRT6 interactions	METTL3 RRP1B ZDBF2 MED1 RBM39 STAU1 BLM SRRT SETD2 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 RPAP2	6.07e-06	628	122	15	int:SIRT6
Interaction	ECT2 interactions	ELOA METTL3 RRP1B SHFL BAG2 RBM23 BLM SRRT UTP15 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 RAI14 THRAP3 MRPL1 RPAP2	6.47e-06	887	122	18	int:ECT2
Interaction	NEIL1 interactions	REXO4 RRP1B U2SURP CENPU STAU1 PRKRA CEBPZ RRP12 CTNNBL1 TARBP2	7.06e-06	276	122	10	int:NEIL1
Interaction	FBL interactions	ELOA REXO4 RRP1B MAP3K14 CHMP4B RBM23 RBM39 STAU1 UTP15 CEBPZ TRIM28 RRP12 NUFIP2 PWP2 RP9	7.47e-06	639	122	15	int:FBL
Interaction	RPL3 interactions	REXO4 RRP1B MAP3K14 CHMP4B RBM39 STAU1 CENPQ PRKRA PDE12 CEBPZ RRP12 KMT2A DGCR8 CPNE4 TARBP2 MRPL1	7.49e-06	722	122	16	int:RPL3
Interaction	ADARB1 interactions	REXO4 RRP1B CDK12 U2SURP CENPU NBN MED1 STAU1 PRKRA BLM CEBPZ RRP12 TARBP2	8.54e-06	489	122	13	int:ADARB1
Interaction	OFD1 interactions	CEP162 BAG2 NBN MCM10 CHMP4B BICD1 AGBL4 C2CD3 RP9 PCNT RPAP2	8.61e-06	347	122	11	int:OFD1
Interaction	OASL interactions	REXO4 RRP1B STAU1 PRKRA CEBPZ TRIM28 RRP12 KMT2A DGCR8	8.75e-06	223	122	9	int:OASL
Interaction	H3C3 interactions	ELOA REXO4 HIVEP1 RRP1B HMGXB4 TEAD1 MED1 BLM FSIP2 CCNL1 KMT2A MLLT6 NIPBL	9.72e-06	495	122	13	int:H3C3
Interaction	CDK12 interactions	ELOA CDK12 MED1 RBM39 PRKRA TRIM28 MLLT1 DGCR8 THRAP3	1.04e-05	228	122	9	int:CDK12
Interaction	BMI1 interactions	BAG2 NBN CHMP4B STAU1 PRKRA SRRT TRIM28 RRP12 NUFIP2 H1-0 CBX7 KMT2A MLLT1 DGCR8 THRAP3	1.08e-05	659	122	15	int:BMI1
Interaction	KLF15 interactions	HIVEP1 ARID4B RRP1B SHFL STAU1 BLM KMT2C RRP12 NIPBL MRPL1	1.09e-05	290	122	10	int:KLF15
Interaction	DHX8 interactions	ELOA CDK12 U2SURP PNISR RBM39 STAU1 BLM SETD2 TRIM28 THRAP3	1.15e-05	292	122	10	int:DHX8
Interaction	PAXIP1 interactions	CDK12 U2SURP CENPU NBN TEAD1 STAU1 BLM KMT2C MAST1 KMT2A THRAP3	1.18e-05	359	122	11	int:PAXIP1
Interaction	CHD4 interactions	ELOA REXO4 RRP1B U2SURP HMGXB4 BAG2 RBM39 STAU1 SRRT PHF20L1 TRIM28 RRP12 NUFIP2 H1-0 PWP2 KMT2A THRAP3 PCNT	1.38e-05	938	122	18	int:CHD4
Interaction	RC3H1 interactions	REXO4 RRP1B CDK12 C19orf53 U2SURP BAG2 RBM39 STAU1 PRKRA TRIM28 RRP12 NUFIP2 H1-0 THRAP3 MRPL1	1.48e-05	677	122	15	int:RC3H1
Interaction	NHLH1 interactions	REXO4 HIVEP1 ARID4B RRP1B BLM KMT2A	1.57e-05	88	122	6	int:NHLH1
Interaction	LHX2 interactions	REXO4 HIVEP1 ARID4B RRP1B STAU1 BLM KMT2C RRP12	1.58e-05	183	122	8	int:LHX2
Interaction	USP36 interactions	ELOA REXO4 RRP1B U2SURP BAG2 CENPU STAU1 BLM UTP15 CEBPZ TRIM28 RRP12 PWP2 DGCR8	1.61e-05	599	122	14	int:USP36
Interaction	DGCR8 interactions	METTL3 REXO4 RRP1B CDK12 CENPU STAU1 CENPQ PRKRA DGCR8	1.68e-05	242	122	9	int:DGCR8
Interaction	NOC3L interactions	REXO4 STAU1 PRKRA CEBPZ RRP12 PWP2 MAST1 DGCR8 TARBP2	1.79e-05	244	122	9	int:NOC3L
Interaction	RNF113A interactions	RRP1B U2SURP RBM39 STAU1 PRKRA TRIM28 CXCR4 RRP12 MCM3AP NUFIP2 H1-0 RP9 TARBP2 THRAP3 SENP5	1.91e-05	692	122	15	int:RNF113A
Interaction	KRR1 interactions	REXO4 RRP1B U2SURP RBM39 STAU1 PRKRA BLM UTP15 RRP12 MAST1 KMT2A	1.96e-05	379	122	11	int:KRR1
Interaction	RPS14 interactions	METTL3 REXO4 CDK12 CHMP4B RBM39 STAU1 CENPQ PRKRA BLM PDE12 CEBPZ TRIM28 RRP12	1.96e-05	529	122	13	int:RPS14
Interaction	RPS6 interactions	ERICH1 ELOA REXO4 RRP1B CDK12 DCC CHMP4B RBM39 STAU1 PRKRA BLM PDE12 CEBPZ TRIM28 RRP12 PWP2 MRPL1	2.07e-05	874	122	17	int:RPS6
Interaction	FZR1 interactions	ARID4B RRP1B CDK12 C19orf53 BAG2 CAPNS2 CENPU RBM39 STAU1 SRRT CEBPZ TRIM28 NUFIP2 H1-0 PWP2 CTNNBL1 TCF25 CTNNA2 CLSPN MRPL1	2.41e-05	1172	122	20	int:FZR1
Interaction	LINC02910 interactions	ELOA CDK12 U2SURP CENPU RBM23 RP9	2.44e-05	95	122	6	int:LINC02910
Interaction	PUM3 interactions	REXO4 RBM39 STAU1 PRKRA CEBPZ TRIM28 MAST1 DGCR8 CPNE4	2.46e-05	254	122	9	int:PUM3
Interaction	ANOS1 interactions	REXO4 RRP1B STAU1 BLM CEBPZ PWP2 KMT2A	2.65e-05	143	122	7	int:ANOS1
Interaction	NIPBL interactions	ZDBF2 TEAD1 PNISR STAU1 TRIM28 NIPBL THRAP3 PCNT	2.89e-05	199	122	8	int:NIPBL
Interaction	DDX21 interactions	REXO4 RRP1B U2SURP CHMP4B RBM23 RBM39 STAU1 CENPQ PRKRA SRRT CEBPZ TRIM28 RRP12 CTNNBL1 THRAP3	2.93e-05	718	122	15	int:DDX21
Interaction	KCTD13 interactions	HTRA1 TNC PPFIA4 BAG2 RBM39 STAU1 PRKRA AGBL4 SRRT CRACD TRIM28 CLMN NUFIP2 H1-0 MAST1 KMT2A RAI14 CTNNA2 CPNE4 CTNND2 FH THRAP3	2.98e-05	1394	122	22	int:KCTD13
Interaction	ZC3H10 interactions	REXO4 HIVEP1 RRP1B STAU1 PRKRA CEBPZ MLLT6 DGCR8	3.00e-05	200	122	8	int:ZC3H10
Interaction	RBM4B interactions	METTL3 REXO4 U2SURP RBM39 STAU1 UTP15 CEBPZ RRP12 TARBP2	3.14e-05	262	122	9	int:RBM4B
Interaction	JMJD6 interactions	U2SURP HMGXB4 CHMP4B RBM23 RBM39 SETD2 CCNL1 RP9	3.57e-05	205	122	8	int:JMJD6
Interaction	CENPN interactions	REXO4 CENPU CENPQ PRKRA DGCR8	3.68e-05	62	122	5	int:CENPN
Interaction	PARP1 interactions	ELOA REXO4 HIVEP1 ARID4B RRP1B U2SURP MED1 RBM39 STAU1 BLM CEBPZ TRIM28 RRP12 H1-0 MLLT1 MLLT6 DGCR8 CLSPN TOPORS NIPBL THRAP3	3.96e-05	1316	122	21	int:PARP1
Interaction	HDAC4 interactions	ARID4B BAG2 RALGPS2 RBM39 STAU1 PRKRA SRRT TRIM28 CLMN NUFIP2 ANKRD11 FMN2 MYOCD SH3RF3 THRAP3	4.40e-05	744	122	15	int:HDAC4
Interaction	MEN1 interactions	REXO4 RRP1B U2SURP BAG2 NBN MED1 SRRT KMT2C PHF20L1 CEBPZ TRIM28 RRP12 MCM3AP NUFIP2 PWP2 TCF25 KMT2A THRAP3	4.69e-05	1029	122	18	int:MEN1
Interaction	H2AB2 interactions	REXO4 RBM23 STAU1 CEBPZ RRP12 PWP2	4.77e-05	107	122	6	int:H2AB2
Interaction	MAGEB10 interactions	REXO4 RRP1B STAU1 PRKRA CEBPZ	4.98e-05	66	122	5	int:MAGEB10
Interaction	FGF3 interactions	CENPU STAU1 CEBPZ RRP12 PWP2	4.98e-05	66	122	5	int:FGF3
Interaction	C2CD3 interactions	CEP162 BICD1 AGBL4 C2CD3	5.15e-05	34	122	4	int:C2CD3
Interaction	PIP4K2A interactions	ELOA RRP1B PNISR STAU1 SETD2 CXCR4 NUFIP2 MLLT1	5.17e-05	216	122	8	int:PIP4K2A
Interaction	C7orf50 interactions	REXO4 STAU1 PRKRA CEBPZ PWP2 MAST1 DGCR8 PCNT	5.52e-05	218	122	8	int:C7orf50
Interaction	EHHADH interactions	ELOA CENPU MCM10 RBM39 CENPQ PRKRA RP9	5.66e-05	161	122	7	int:EHHADH
Cytoband	16q24.3	ANKRD11 TCF25 JPH3	4.04e-04	52	126	3	16q24.3
Cytoband	21q22.3	RRP1B MCM3AP PWP2 PCNT	4.44e-04	128	126	4	21q22.3
GeneFamily	PHD finger proteins	KMT2C PHF20L1 TRIM28 KMT2A MLLT6	4.07e-05	90	77	5	88
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2C SETD2 KMT2A	4.04e-04	34	77	3	487
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	RRP1B SLC7A14 STAU1 TRIM28 ELFN1	1.05e-03	181	77	5	694
Coexpression	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	ELOA HIVEP1 ARID4B TAGAP PARP8 KMT2C PHF20L1 UTP15 USPL1	4.92e-07	197	126	9	M4237
Coexpression	GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	ELOA HIVEP1 CDK12 NBN CEBPZ RRP12 USPL1 SH3RF3 NIPBL	5.13e-07	198	126	9	M4247
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	GALC HIVEP1 CDK12 HMGXB4 CENPU ZDBF2 PNISR RBM39 PDE12 PHF20L1 CEBPZ RRP12 CCNL1 PHACTR1 SENP5	1.00e-06	680	126	15	M41089
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP1 U2SURP HMGXB4 MAP3K14 SPART NBN TEAD1 MED1 PNISR RBM39 BICD1 BLM SETD2 C2CD3 NIPBL PCNT	3.64e-06	856	126	16	M4500
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	RRP1B CDK12 PARP8 U2SURP ZDBF2 PNISR RBM39 CXCR4 CCNL1 ANKRD11 USPL1	7.98e-06	432	126	11	M41149
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ARID4B TAGAP SHFL PARP8 U2SURP SAMSN1 MED1 PNISR RBM39 KMT2C SETD2 PHF20L1 CXCR4 CCNL1 NUFIP2 ANKRD11 CBX7 KMT2A MLLT6 NIPBL THRAP3	8.65e-06	1492	126	21	M40023
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	HTRA1 TEAD1 BICD1 BMPR2 UNC5C ANKRD11 FMN2 RAI14	8.90e-06	212	126	8	M39221
Coexpression	GARY_CD5_TARGETS_DN	ELOA RRP1B CDK12 BAG2 RALGPS2 SRRT UTP15 CEBPZ ZNF506 CLSPN MRPL1	9.48e-06	440	126	11	M13893
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	ARID4B PNISR RBM39 CEBPZ CCNL1 NIPBL SENP5	1.62e-05	166	126	7	M8129
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	REXO4 ARID4B PARP8 TEAD1 C2CD3 CLMN TCF25	1.62e-05	166	126	7	M6826
Coexpression	GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP	SHFL CDK12 DDX60 MED1 PNISR C2CD3 KMT2A	1.96e-05	171	126	7	M5655
Coexpression	VILLANUEVA_LIVER_CANCER_KRT19_UP	RRP1B HMGXB4 MCM10 BLM ALMS1 CTNND2 JPH3	2.27e-05	175	126	7	M336
Coexpression	MARSON_BOUND_BY_E2F4_UNSTIMULATED	ZNF438 CENPU NBN MCM10 STARD6 CENPQ BLM ALMS1 MAST1 DGCR8 FH CLSPN PCNT	4.14e-05	714	126	13	M1744
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	ARID4B TNC SPART PNISR STAU1 PHF20L1 UTP15 NUFIP2 MLLT1 DGCR8 THRAP3	4.32e-05	519	126	11	M3395
Coexpression	GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	ELOA HIVEP1 CDK12 SETD2 CXCR4 USPL1 NIPBL	4.68e-05	196	126	7	M4244
Coexpression	GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	SPART C1orf141 BMPR2 CLMN CBX7 KMT2A MAML2	4.68e-05	196	126	7	M9241
Coexpression	GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN	HTRA1 TAGAP SAMSN1 SETD2 MAML2 TOPORS THRAP3	4.99e-05	198	126	7	M7229
Coexpression	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	DDX60 PNISR C2CD3 CXCR4 CLMN CBX7 DGCR8	5.15e-05	199	126	7	M4444
Coexpression	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	KMT2C PHF20L1 PWP2 CBX7 MLLT6 USPL1 PCNT	5.32e-05	200	126	7	M9439
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	ARID4B TNC SPART PNISR STAU1 PHF20L1 UTP15 NUFIP2 MLLT1 DGCR8 THRAP3	6.48e-05	543	126	11	MM997
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	CDK12 PNISR RBM39 PRKRA SETD2 PHF20L1 CEBPZ MAML2 USPL1	6.74e-05	363	126	9	M41103
Coexpression	YAP1_UP	C8orf48 TEAD1 SAMSN1 MAML2	7.74e-05	47	126	4	M2845
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	ARID4B CENPU NBN PNISR CENPQ BLM PHF20L1 CEBPZ CCNL1 RAI14 CTNND2 NIPBL	7.93e-05	656	126	12	M18979
Coexpression	LINDSTEDT_DENDRITIC_CELL_MATURATION_B	HIVEP1 MAP3K14 NBN CXCR4	9.12e-05	49	126	4	M12480
Coexpression	BASAKI_YBX1_TARGETS_DN	HTRA1 CDK12 PARP8 RALGPS2 SPART NBN PNISR RBM39 BICD1	1.35e-04	398	126	9	M14877
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN	PARP8 HMGXB4 MED1 NEO1 CLMN H1-0 KMT2A NIPBL SENP5	1.38e-04	399	126	9	M40939
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	HMGXB4 BAG2 CENPU MCM10 CHMP4B RBM23 CENPQ BLM ALMS1 TRIM28 DGCR8 FH CLSPN PCNT	1.74e-04	939	126	14	M45768
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	NBN BLM KMT2A MLLT1 MLLT6 MAML2 FH THRAP3	1.74e-04	323	126	8	M9150
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ARID4B CEP162 U2SURP ZDBF2 MCM10 DCC CHMP4B PNISR BICD1 CENPQ BLM CRACD SETD2 ALMS1 CEBPZ CXCR4 MAST1 FMN2 RP9 CTNND2 CLSPN NIPBL PCNT	7.71e-09	989	121	23	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	CDK12 ZDBF2 TEAD1 CENPQ ALMS1 PHF20L1 CEBPZ CCNL1 ANKRD11 CTNND2 CLSPN TOPORS NIPBL THRAP3 PCNT	3.72e-07	532	121	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ARID4B RRP1B CENPU NBN ZDBF2 MCM10 CHMP4B PNISR BICD1 CENPQ BLM XYLT1 CRACD ALMS1 ZNF506 FAM149B1 FH CLSPN TOPORS NIPBL THRAP3	8.07e-06	1257	121	21	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ARID4B CEP162 CHMP4B PNISR BLM ALMS1 CEBPZ RP9 CLSPN NIPBL	1.19e-05	311	121	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	CDK12 ZDBF2 BICD1 ALMS1 PHF20L1 ANKRD11 CTNND2 SH3RF3 NIPBL	1.79e-05	259	121	9	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ARID4B RRP1B CENPU NBN ZDBF2 MCM10 CHMP4B PNISR INKA2 BICD1 CENPQ BLM XYLT1 CRACD ALMS1 ZNF506 FAM149B1 FH CLSPN TOPORS NIPBL THRAP3	2.37e-05	1459	121	22	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	TNC PRR15L ZDBF2 BICD1 XYLT1 BMPR2 ALMS1 CEBPZ ANKRD11 MAST1 FMN2 MLLT6 CTNND2 CLSPN SH3RF3 PCNT PHACTR1	4.24e-05	983	121	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ELOA CEP162 ZDBF2 CHMP4B PNISR CRACD SETD2 ALMS1 CEBPZ FMN2 RP9 FAM149B1 CTNND2 CLSPN NIPBL	7.74e-05	831	121	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	CDK12 PNISR CENPQ ALMS1 PHF20L1 CEBPZ ANKRD11 CLSPN TOPORS SH3RF3 NIPBL	7.81e-05	469	121	11	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000	CDK12 BAG2 MAP3K14 ZDBF2 RBM39 BICD1 ALMS1 PHF20L1 CTNNBL1 ANKRD11 TCF25 DGCR8 CTNNA2 CTNND2 SH3RF3 NIPBL	1.67e-04	994	121	16	Facebase_RNAseq_e8.5_Floor Plate_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	ZDBF2 TEAD1 CENPQ CEBPZ CTNND2 TOPORS PCNT	1.71e-04	204	121	7	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	METTL3 ARID4B RRP1B NBN ZDBF2 BICD1 CENPQ BLM ALMS1 UNC5C ZNF506 PWWP3A FH CLSPN TOPORS NIPBL TARBP2 THRAP3	2.31e-04	1241	121	18	facebase_RNAseq_e10.5_MandArch_2500_K1
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B DDX60 PNISR RBM39 KMT2C SETD2 CCNL1 NUFIP2 ANKRD11 TCF25 KMT2A NIPBL	5.34e-13	200	126	12	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B ZDBF2 PNISR C3orf20 RBM39 KMT2C ELFN1 CCNL1 ANKRD11 TCF25 KMT2A	1.12e-11	197	126	11	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA4 SETD2 CEBPZ CCNL1 NUFIP2 ANKRD11 KMT2A NIPBL THRAP3	2.87e-09	184	126	9	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ARID4B DDX60 PNISR RBM39 KMT2C CXCR4 CCNL1 ANKRD11 TCF25	5.21e-09	197	126	9	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ARID4B RBM39 KMT2C CCNL1 NUFIP2 ANKRD11 KMT2A NIPBL	6.60e-08	188	126	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARID4B DDX60 RBM39 KMT2C CXCR4 CCNL1 ANKRD11 TCF25	9.84e-08	198	126	8	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARID4B DDX60 RBM39 KMT2C CXCR4 CCNL1 ANKRD11 TCF25	9.84e-08	198	126	8	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ARID4B RBM39 KMT2C SETD2 CCNL1 ANKRD11 KMT2A NIPBL	1.06e-07	200	126	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	ARID4B TAGAP PNISR RBM39 CXCR4 CCNL1 ANKRD11 TCF25	1.06e-07	200	126	8	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	Severe-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID4B TAGAP DDX60 CAPNS2 RBM23 CXCR4 PHACTR1	5.85e-07	171	126	7	61205a4986c2d0a89aea96ed8dec9e952eeb6ff1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 SLC7A14 CRACD UNC5C FMN2 CPNE4	8.57e-07	181	126	7	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 SLC7A14 CRACD UNC5C FMN2 CPNE4	8.57e-07	181	126	7	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ARID4B SHFL CDK12 DDX60 KMT2C SETD2 CCNL1	9.22e-07	183	126	7	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	AMER1 ARID4B CDK12 MED1 CRACD BMPR2 ALMS1	1.03e-06	186	126	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARID4B CDK12 RBM39 CEBPZ CCNL1 ANKRD11 NIPBL	1.07e-06	187	126	7	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARID4B CDK12 RBM39 CEBPZ CCNL1 ANKRD11 NIPBL	1.10e-06	188	126	7	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TAGAP RALGPS2 NBN SAMSN1 DCC PNISR CXCR4	1.10e-06	188	126	7	2156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCell	Severe-B_activate-7\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID4B TAGAP DDX60 RALGPS2 RBM23 CXCR4 PHACTR1	1.18e-06	190	126	7	67e6c8a5a8724bdf2861fd76a711319dfc71d47a
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ARID4B RBM39 KMT2C RRP12 CCNL1 KMT2A MAML2	1.27e-06	192	126	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 SLC7A14 KMT2C ANKRD11 FMN2 KMT2A PHACTR1	1.41e-06	195	126	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 SLC7A14 KMT2C ANKRD11 FMN2 KMT2A PHACTR1	1.41e-06	195	126	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Mild/Remission\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID4B TAGAP DDX60 PNISR RBM39 CXCR4 CCNL1	1.46e-06	196	126	7	71603a3b7df40eb3f267345f55e44a812fea7926
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CEBPZ CXCR4 ANKAR MAST1 THRAP3 PCNT	4.75e-06	152	126	6	5adcdf93fd3ca066402aaaf308c363e4648f871d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPU MCM10 BLM XYLT1 CRACD CLSPN	9.32e-06	171	126	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPU MCM10 BLM XYLT1 CRACD CLSPN	9.32e-06	171	126	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MGAT4B PNISR RBM39 CTNND2 TOPORS RPAP2	1.06e-05	175	126	6	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAGAP NBN SAMSN1 CXCR4 CCNL1 PHACTR1	1.13e-05	177	126	6	fd739ae4a574b72dc26a2a9ff4ef988454298ead
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HTRA1 BAG2 MCM10 BLM MLLT1 CLSPN	1.21e-05	179	126	6	9dea57494d59abd6e8abf34e31faf53462ea0fa0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIA4 SLC7A14 CRACD UNC5C FMN2 CPNE4	1.21e-05	179	126	6	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC XYLT1 CRACD UNC5C SH3RF3	1.70e-05	190	126	6	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC CRACD UNC5C MYOCD SH3RF3	1.70e-05	190	126	6	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC XYLT1 CRACD UNC5C SH3RF3	1.70e-05	190	126	6	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAGAP NBN SAMSN1 CXCR4 CCNL1 PHACTR1	1.70e-05	190	126	6	212f0d9defcc3174e225cc3d90e7814e238794b6
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HTRA1 CENPU MCM10 BLM MYOCD CLSPN	1.70e-05	190	126	6	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC XYLT1 CRACD UNC5C SH3RF3	1.75e-05	191	126	6	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAGAP NBN SAMSN1 CXCR4 CCNL1 PHACTR1	1.75e-05	191	126	6	4d7f6216958fb202426b7a102e74682105ce7fca
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAGAP NBN SAMSN1 CXCR4 CCNL1 PHACTR1	1.75e-05	191	126	6	e979f6768065b8b3e522d66999ca794d844eccb4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC XYLT1 CRACD UNC5C SH3RF3	1.80e-05	192	126	6	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC XYLT1 CRACD UNC5C SH3RF3	1.80e-05	192	126	6	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	PNISR SRRT CCNL1 ANKRD11 TCF25 KMT2A	1.80e-05	192	126	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC XYLT1 CRACD UNC5C SH3RF3	1.85e-05	193	126	6	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HTRA1 CENPU MCM10 BLM MYOCD CLSPN	1.85e-05	193	126	6	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HTRA1 CENPU MCM10 BLM MYOCD CLSPN	1.85e-05	193	126	6	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	ARID4B SHFL DDX60 SAMSN1 RBM39 CXCR4	1.85e-05	193	126	6	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 ARID4B CDK12 ANKRD11 NIPBL THRAP3	1.91e-05	194	126	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	HTRA1 CENPU MCM10 BLM MYOCD CLSPN	1.91e-05	194	126	6	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAGAP SAMSN1 CXCR4 CCNL1 MLLT6 PHACTR1	1.91e-05	194	126	6	d2f6c8900b5c448eede8047ca964e94b19bd6ca5
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID4B PARP8 PNISR RBM39 CXCR4 KMT2A	2.08e-05	197	126	6	ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3
ToppCell	10x3'2.3-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	TAGAP PNISR CCNL1 NUFIP2 ANKRD11 PHACTR1	2.08e-05	197	126	6	f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC BICD1 XYLT1 MAML2 SH3RF3	2.08e-05	197	126	6	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC BICD1 XYLT1 MAML2 SH3RF3	2.08e-05	197	126	6	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TAGAP SAMSN1 RBM39 CXCR4 CCNL1 MRPL1	2.14e-05	198	126	6	ec115c4a5dbc54206c72140aa0c8d6a7c29c5563
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PARP8 PNISR RBM39 CXCR4 CCNL1 KMT2A	2.14e-05	198	126	6	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAGAP NBN SAMSN1 CXCR4 CCNL1 PHACTR1	2.14e-05	198	126	6	ecd93e28bae4152467f6d6621cffc73c301c9795
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TAGAP SHFL DDX60 PARP8 SAMSN1 CXCR4	2.20e-05	199	126	6	d3f36ede2fade550ec8f21a0448e71e1ff579ee2
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PARP8 PNISR RBM39 CCNL1 ANKRD11 TCF25	2.20e-05	199	126	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX60 PARP8 ZDBF2 NEO1 CXCR4 MLLT6	2.20e-05	199	126	6	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	Severe\|World / Disease group and Cell class	CENPU MCM10 CHMP4B BLM CXCR4 CLSPN	2.20e-05	199	126	6	b73ae402b258fcc17e6cd6d6045244eccfe38ef8
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX60 PARP8 RBM39 CXCR4 KMT2A MLLT6	2.26e-05	200	126	6	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	10x_5'_v1-Non-neoplastic\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARID4B TAGAP PARP8 SAMSN1 RBM39 CXCR4	2.26e-05	200	126	6	88e94b067da1068b2ff1f95c730f2a49c66d7fe6
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PARP8 RBM39 CEBPZ CXCR4 KMT2A MLLT6	2.26e-05	200	126	6	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SAMSN1 PNISR RBM39 ANKRD11 PHACTR1	4.12e-05	135	126	5	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ARID4B PARP8 ANKRD11 RAI14 NIPBL	4.58e-05	138	126	5	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH2 DCC CTNNA2 CPNE4 CTNND2	5.98e-05	146	126	5	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	7.94e-05	155	126	5	90e629681a72baacc7981b82883866a487638dbc
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	7.94e-05	155	126	5	e7f49e2fdaf184fa6b4e685518004e7deff1316d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	7.94e-05	155	126	5	5a872ca70ae8c30b57f45a6772d7bf565e0c2663
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	PARP8 RBM39 KMT2C CCNL1 MAML2	8.19e-05	156	126	5	1545169694f686d28648a68b552c2ae606599d66
ToppCell	facs-Aorta-Heart-24m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRP1B PPFIA4 MAP3K14 RALGPS2 CTNND2	1.13e-04	167	126	5	b85fd7ab21c80470bca804c788ce49a2bce763f8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.16e-04	168	126	5	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.16e-04	168	126	5	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.16e-04	168	126	5	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CAPNS2 SAMSN1 GSN-AS1 CCNL1 PWP2	1.19e-04	169	126	5	0867528101767fc65e93b3561480bf830c50368d
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	AMER1 ZDBF2 FSIP2 SETD2 PDE12	1.19e-04	169	126	5	bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	AMER1 CENPU RAI14 CLSPN SH3RF3	1.26e-04	171	126	5	b113fbebb89056af0b9c775d2fb6552206a80467
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPU MCM10 XYLT1 CLSPN SH3RF3	1.30e-04	172	126	5	eba1568d4307e91c94fc616549057cbed8df5840
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.30e-04	172	126	5	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	BAL-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.33e-04	173	126	5	5b76d9cc56bbb29017e64a2d0a3c76c0be003d96
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.33e-04	173	126	5	bf685025961e79b379f2c35464b6c8ce3e31ace0
ToppCell	BAL-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.33e-04	173	126	5	a6e73a40b0d5356564a594053e772f9d061a5919
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.33e-04	173	126	5	a8b5370f4c893a20c58e97659f3ac168699693f8
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.33e-04	173	126	5	1edef5aeab626cbf2c09468e77b02cfa2d21ba03
ToppCell	Mild/Remission-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID4B TAGAP RALGPS2 CXCR4 PHACTR1	1.33e-04	173	126	5	694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.33e-04	173	126	5	c37dba3804df7c3151e18e6ae4e0b6e7a92bae97
ToppCell	10x5'-blood-Lymphocytic_Invariant-Inducer-like\|blood / Manually curated celltypes from each tissue	PARP8 NEO1 CXCR4 MAST1 CTNND2	1.37e-04	174	126	5	51be6f29308c01593978cbee92114151a5916c9c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.37e-04	174	126	5	dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 CLMN UNC5C MYOCD SH3RF3	1.40e-04	175	126	5	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.40e-04	175	126	5	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA1 BMPR2 NUFIP2 MYOCD THRAP3	1.44e-04	176	126	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	AMER1 ZDBF2 FSIP2 SETD2 PDE12	1.44e-04	176	126	5	7a74217b7fa1032b918f00a3972dff5fab74671a
ToppCell	Severe_COVID-19-Myeloid-Neutrophil\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.48e-04	177	126	5	a6fae376f1beb1df423484d9b1bd1d954ca117af
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	INKA2 CXCR4 MAML2 TOPORS PHACTR1	1.48e-04	177	126	5	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.48e-04	177	126	5	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 ARID4B CDK12 BMPR2 ANKRD11	1.52e-04	178	126	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Severe-Myeloid-Neutrophil\|Severe / Condition, Lineage, Cell class and cell subclass	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.52e-04	178	126	5	454313efe59d71e7327b9758efabf2d893e4a8fd
ToppCell	Severe-Myeloid-Neutrophil-\|Severe / Condition, Lineage, Cell class and cell subclass	TAGAP NBN CXCR4 CCNL1 PHACTR1	1.52e-04	178	126	5	8618ae891d62bf70fe860ff7bb2d31868961aa13
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HTRA1 PPFIA4 CRACD UNC5C FMN2	1.52e-04	178	126	5	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 TEAD1 RP1 CTNND2 PHACTR1	1.56e-04	179	126	5	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPU MCM10 BLM AGBL4 CLSPN	1.56e-04	179	126	5	80112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPU MCM10 BLM AGBL4 CLSPN	1.60e-04	180	126	5	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
Disease	Nephroblastoma	AMER1 TRIM28 MLLT1 DGCR8	1.34e-05	36	119	4	C0027708
Disease	alcohol dependence, heroin dependence, methamphetamine dependence	AGBL4 CTNNA2	9.63e-05	4	119	2	EFO_0004240, EFO_0004701, MONDO_0007079
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	HIVEP1 TEAD1 DCC XYLT1 BMPR2 ALMS1 PHF20L1 ELFN1 NUFIP2 CTNNA2 CPNE4 PHACTR1	9.85e-05	801	119	12	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	NBN BLM SETD2 KMT2A	1.10e-04	61	119	4	C1961102
Disease	Bilateral Wilms Tumor	AMER1 MLLT1 DGCR8	2.16e-04	29	119	3	C2930471
Disease	Retinitis pigmentosa	SLC7A14 RP9 RP1 TOPORS	2.33e-04	74	119	4	cv:C0035334
Disease	laryngeal carcinoma (is_marker_for)	KMT2C CXCR4	2.39e-04	6	119	2	DOID:2600 (is_marker_for)
Disease	Orofaciodigital Syndromes	C2CD3 FAM149B1	2.39e-04	6	119	2	C0029294
Disease	putamen volume	DCC CTNND2 JPH3	2.65e-04	31	119	3	EFO_0006932
Disease	stomach cancer (is_marker_for)	HTRA1 CDK12 SETD2 CXCR4 CBX7	2.83e-04	142	119	5	DOID:10534 (is_marker_for)
Disease	anti-GAD65 autoimmune neurological syndromes	CHMP4B SRRT NEO1	3.81e-04	35	119	3	EFO_0803379
Disease	migraine disorder, Headache	HTRA1 NUFIP2 JPH3 PHACTR1	4.14e-04	86	119	4	HP_0002315, MONDO_0005277
Disease	Cornelia De Lange Syndrome	KMT2A NIPBL	4.44e-04	8	119	2	C0270972
Disease	N2,N2-dimethylguanosine measurement	ALMS1 SH3RF3	4.44e-04	8	119	2	EFO_0021125
Disease	Neurodevelopmental Disorders	KMT2C SETD2 ANKRD11 KMT2A	5.57e-04	93	119	4	C1535926
Disease	total hip arthroplasty, osteoarthritis	FILIP1 TNC H1-0	6.55e-04	42	119	3	EFO_0009806, MONDO_0005178
Disease	Leukemia, Myelocytic, Acute	BLM KMT2C SETD2 H1-0 KMT2A	6.97e-04	173	119	5	C0023467
Disease	esophagus squamous cell carcinoma (is_implicated_in)	HTRA1 DCC KMT2C	8.02e-04	45	119	3	DOID:3748 (is_implicated_in)
Disease	Retinitis Pigmentosa	SLC7A14 RP9 RP1 TOPORS	8.47e-04	104	119	4	C0035334
Disease	GM3 ganglioside measurement	PRR15L CTNND2	8.66e-04	11	119	2	EFO_0021451
Disease	hair colour measurement	PARP8 CHMP4B NEO1 CTNNBL1 ANKRD11 TCF25 FMN2 RAI14 JPH3	8.88e-04	615	119	9	EFO_0007822
Disease	lung adenocarcinoma (is_implicated_in)	HTRA1 KMT2C SETD2	1.03e-03	49	119	3	DOID:3910 (is_implicated_in)
Disease	methionine sulfone measurement	CDK12 ALMS1	1.04e-03	12	119	2	EFO_0800072
Disease	pain	HTRA1 DCC NUFIP2 JPH3 PHACTR1	1.22e-03	196	119	5	EFO_0003843
Disease	pulmonary hypertension (implicated_via_orthology)	TNC BMPR2 CXCR4	1.37e-03	54	119	3	DOID:6432 (implicated_via_orthology)
Disease	leukemia	BLM SETD2 KMT2A	1.44e-03	55	119	3	C0023418
Disease	vital capacity	ZNF438 FILIP1 HTRA1 CDK12 CEP162 MAP3K14 RALGPS2 TEAD1 MED1 DCC STAU1 CXCR4 CTNNA2	1.47e-03	1236	119	13	EFO_0004312
Disease	colorectal cancer (is_implicated_in)	AMER1 DCC SETD2 CTNNBL1	1.49e-03	121	119	4	DOID:9256 (is_implicated_in)
Disease	Replication Error Phenotype	SETD2 TARBP2	1.64e-03	15	119	2	C1721098
Disease	Microsatellite Instability	SETD2 TARBP2	1.64e-03	15	119	2	C0920269
Disease	Moyamoya Disease	HTRA1 PCNT	2.11e-03	17	119	2	C0026654
Disease	1-Methylhistidine measurement	CDK12 ALMS1	2.11e-03	17	119	2	EFO_0021543
Disease	response to clozapine	ZNF438 CTNNA2	2.37e-03	18	119	2	GO_0097338
Disease	joint damage measurement	ERICH1 PARP8 MAP3K14	2.65e-03	68	119	3	EFO_0005413
Disease	schizophrenia, intelligence, self reported educational attainment	TEAD1 DCC RBM23 STAU1 KMT2A MAML2	2.85e-03	346	119	6	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	Osteoarthritis of hip	FILIP1 TNC	2.92e-03	20	119	2	C0029410
Disease	wellbeing measurement, alcohol consumption measurement	GALC CDK12 CPNE4	3.37e-03	74	119	3	EFO_0007869, EFO_0007878
Disease	urate measurement, bone density	HMGXB4 FSIP2 ANKRD11 MAML2 CTNNA2 CTNND2 SH3RF3 JPH3	3.67e-03	619	119	8	EFO_0003923, EFO_0004531
Disease	colorectal cancer (is_marker_for)	HTRA1 AMER1 SETD2 CXCR4	3.81e-03	157	119	4	DOID:9256 (is_marker_for)
Disease	neutrophil count	HIVEP1 TAGAP PARP8 TEAD1 SETD2 CXCR4 RRP12 NUFIP2 ANKRD11 CBX7 RP1 CPNE4 PCNT	3.85e-03	1382	119	13	EFO_0004833
Disease	Self-injurious behavior	DCC MYOCD NIPBL	3.90e-03	78	119	3	HP_0100716

Protein segments in the cluster

Peptide	Gene	Start	Entry
GSSSKKQKRSHKATV	ARID4B	1126	Q4LE39
HTDGTTISKNKKRKL	ERICH1	151	Q86X53
TGLKEKKHKASKRSR	MLLT6	461	P55198
KERELKSGHKDRSKS	CDK12	186	Q9NYV4
KKAASAAAAGSLKKT	ELFN1	451	P0C7U0
FKAGHTTVDDKLKKK	C1orf141	286	Q5JVX7
KHTNLKHGKTAASKR	CENPQ	56	Q7L2Z9
HKDTHGKDKERKASL	ANKRD11	1066	Q6UB99
HEQSRRSKGKLGKSK	BICD1	801	Q96G01
LSHSKGHQKRKALKT	CXCR4	226	P61073
KKISRSSALKVLDHA	CTNNBL1	346	Q8WYA6
AKPKRAKASKKSTDH	H1-0	11	P07305
SLEKSHKNTGELKKS	ALMS1	3681	Q8TCU4
EKRSKHSKKVLNTGH	ALMS1	3821	Q8TCU4
HDKRKKSRSKAIGSD	CENPU	216	Q71F23
SKKGLSKSKTHDGLS	AMER1	86	Q5JTC6
LTAAKKHGTKNKRAA	CHMP4B	51	Q9H444
DLKSSNRHGHKRKKS	CCNL1	456	Q9UK58
GTASSKKLAKNKAAR	DGCR8	556	Q8WYQ5
SKGDKHSPKVVKAAS	CTNND2	996	Q9UQB3
ASLLGKKGASATKHD	RAI14	36	Q9P0K7
GETSKKKRSRSHNKS	RBM23	56	Q86U06
NGHEERSKKRKKSKS	RBM39	26	Q14498
GLFKATKKTKDSHNI	ANKAR	1381	Q7Z5J8
RGDSKKKTSSRHKKL	C8orf48	136	Q96LL4
KKRATHSAGKRKGSQ	DCC	1131	P43146
KSKLKSEQDGISKTH	PARP8	301	Q8N3A8
QIGAHRKSKKALSAK	KMT2C	3201	Q8NEZ4
QKVKKRSLSKGSGHF	INKA2	246	Q9NTI7
THSSLAGKIQKLKDK	MGAT4B	371	Q9UQ53
KSKEDALKHKSSGKI	FSCB	176	Q5H9T9
QDSLHKGAKRKGIKS	PPFIA4	741	O75335
HASAALARKKGKSLH	MCM3AP	481	O60318
RKFQAHKPAKSKTAA	C19orf53	6	Q9UNZ5
HKPAKSKTAAAASEK	C19orf53	11	Q9UNZ5
SGPKSKKAHETKAEI	DDX60	566	Q8IY21
FTKKTHLGLSAAKAK	FSIP2	2676	Q5CZC0
HLGLSAAKAKSKTKL	FSIP2	2681	Q5CZC0
NALKGHAKAAAAKKS	PDE12	81	Q6L8Q7
KHKQDTKSDSPRLKS	NIPBL	781	Q6KC79
LSSKAKRAKCSTHKQ	NIPBL	1366	Q6KC79
KAKSKHTGILKEAEA	MCM10	736	Q7L590
FLGTDTHKKKRKHSS	HMGXB4	66	Q9UGU5
SESKKEHHRKKVSGS	HMGXB4	141	Q9UGU5
HSLRNHSAKGKKKAL	OR4C11	221	Q6IEV9
SSHSEKKTAKRKGSA	PCNT	31	O95613
AAVKSKSLGDSKNRH	MYOCD	236	Q8IZQ8
GASLSADKKGALRKH	MAST1	1271	Q9Y2H9
AKEPAKKSRKHAASD	METTL3	206	Q86U44
SKTHRSADRAKGKEK	NUTM1	991	Q86Y26
RKKKSEKFKHTSAAL	PHACTR1	126	Q9C0D0
ARKAGKHTKATATAA	MAML2	86	Q8IZL2
KAIKLLEHSKGAGSK	BAG2	186	O95816
ATKALRGKATLLKSH	GSN-AS1	56	Q9NRJ2
KKFLTESHDRQAKGK	HTRA1	361	Q92743
ESHDRQAKGKAITKK	HTRA1	366	Q92743
HFVRVSTAQKSKKGK	BLM	176	P54132
ESSDHKLKKRSAGKR	C2CD3	491	Q4AC94
KGRSKKAHVLAASVE	CTNNA2	51	P26232
HKSSHKDKRPVDAKS	ELOA	271	Q14241
DKAAKIAKTAHKNGS	FH	466	P07954
TKIHTKAKVTSRGKA	C3orf20	636	Q8ND61
QKKKKRHSSTGDSAD	CRACD	866	Q6ZU35
KLSKSLLKHGNTAGK	CPNE4	126	Q96A23
KVLSKHKDLKTDGFS	CAPNS2	106	Q96L46
TKEPRLKFGSKHKSN	BMPR2	766	Q13873
SMDLRSSHKAKGKEK	CBX7	86	O95931
SKGDKKSSVNHKDPS	AGBL4	486	Q5VU57
LKKLHRAASVGDLKK	ANKRD7	26	Q92527
SAKRAKKDVLHSSKG	CEP162	1131	Q5TB80
SAKKATGRKKSSSHD	KMT2A	926	Q03164
KPSHGSKDANKESSK	MLLT1	176	Q03111
EKHGRSSKDKENAKS	FMN2	1416	Q9NZ56
GTHSAKDAKLTGKKL	GALC	256	P54803
KTGLIHSADDFKKKA	DNAH2	1146	Q9P225
EVHSKVSTKKSKRKG	CEBPZ	936	Q03701
KRKKADTEGKSPSHS	MED1	1011	Q15648
KSTKGKHVKVSNSGR	PRR15L	61	Q9BU68
LKATERKHFKSTSNK	RALGPS2	501	Q86X27
RKKKSSKSLAHAGVA	MAP3K14	146	Q99558
TLSSGKARSKKCKHE	PHF20L1	341	A8MW92
KARSKKCKHESGDSS	PHF20L1	346	A8MW92
DSHITLKSQKKRKGD	RP1	861	P56715
TKSHIAAEKSGPEKK	RP1	1036	P56715
FHGKKSEAATEKQKL	FAM149B1	241	Q96BN6
KAKGAESHLRAILKS	PWWP3A	581	Q2TAK8
RTKASGTEHNKKGTK	REXO4	146	Q9GZR2
LSKSLAGAAKHERKA	TAAR5	236	O14804
GILSVKHRKSEAKKE	UTP15	311	Q8TED0
KRKHKSSKSNEGSDS	RP9	206	Q8TA86
SKKKTALGKNHSRKD	RRP1B	261	Q14684
HKKVLTKNLSAGSGK	TAGAP	516	Q8N103
KRHLKTSGECERKTK	FILIP1	56	Q7Z7B0
ASKSHAAEKLRSNKK	NBN	536	O60934
EKEKHQKPKRSSSFG	SAMSN1	11	Q9NSI8
KKKRAACKSVNGSHK	NEO1	1136	Q92859
VSAKLKRWKKGHSSD	RRP12	11	Q5JTH9
KKSSKKRNRKHSGDD	SRRT	346	Q9BXP5
HKDSPRDVSKKAKRS	U2SURP	971	O15042
KKITVSSKASRKFHG	STARD6	31	P59095
KKKADRKSFCTIHST	ARNTL	271	O00327
HAEKLGKRSIKSAHK	CLMN	601	Q96JQ2
TDRKSSKKHIHDKEG	CLSPN	146	Q9HAW4
DAKANGRTSSKAKSK	SLC7A14	736	Q8TBB6
REKFHGKVSSKKAGA	SHFL	16	Q9NUL5
RHFAAATKSAKKTKK	MRPL1	41	Q9BYD6
VKRKDAKHFISSSKT	SENP5	96	Q96HI0
HKGKRGKRAKDTSSE	SPART	381	Q8N0X7
QKASHVSKKARKSAS	USPL1	806	Q5W0Q7
GKEAISALSRAKSKH	XYLT1	261	Q86Y38
HSRVESSKRKSAKEK	THRAP3	166	Q9Y2W1
SSKKFDDRPKGKHAS	NUFIP2	311	Q7Z417
KGKTRQAAKHDAAAK	STAU1	141	O95793
LVGISKKSAEHFKRK	RPAP2	326	Q8IXW5
TGHQSKKKHSRKSKR	SAGE1	41	Q9NXZ1
DGKKNTKKRHSFTAL	SH3RF3	371	Q8TEJ3
RKELDKITAKHAAKG	PWP2	591	Q15269
KITAKHAAKGKAFTA	PWP2	596	Q15269
EKGRHKSKPARVKAS	TNC	1056	P24821
QSKKKIHGKRVTTSS	ZDBF2	2171	Q9HCK1
VLKSKKSSEFLKHAG	SETD2	911	Q9BYW2
GTSKKLAKHRAAEAA	PRKRA	81	O75569
NKGHCDSSTRIKSKK	TOPORS	546	Q9NS56
KSQRSGKKASRKHKS	PNISR	786	Q8TF01
SGTSKKLAKRNAAAK	TARBP2	206	Q15633
KSRDFHSKLKDQTAK	TEAD1	101	P28347
LREVEKSHKSVKGKA	TMC2	796	Q8TDI7
KSHKSVKGKATARDS	TMC2	801	Q8TDI7
SLRHKVAKKGKDVAL	TRBV7-1	26	A0A0A6YYK4
GHSTTKAAAKRLKLA	UNC5C	671	O95185
HKTKLNSGAAKRKGR	ZNF438	371	Q7Z4V0
SEQSHASGKLRKKKK	TCF25	116	Q9BQ70
KSKAHSKKCVDLGVS	HIVEP1	2136	P15822
KFSNSNKHKIRDTGK	ZNF506	156	Q5JVG8
KRLGDKHATLQKSTK	TRIM28	261	Q13263
DFAKSSGLKKHLKTH	ZNF114	396	Q8NC26
HSDSEILKSKKKGLF	JPH3	201	Q8WXH2